{
    "organizations": [],
    "uuid": "5e7f48117c503d4670f3656b7babe23e768da768",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tonix-pharmaceuticals-receives-not/brief-tonix-pharmaceuticals-receives-notice-of-allowance-for-new-u-s-patent-for-the-active-ingredient-in-tonmya-idUSFWN1PI0SI",
    "ord_in_thread": 0,
    "title": "BRIEF-Tonix Pharmaceuticals Receives Notice Of Allowance For New U.S. Patent For The Active Ingredient In Tonmya",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 23 (Reuters) - Tonix Pharmaceuticals Holding Corp :\n* TONIX PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE FOR NEW U.S. PATENT FOR THE ACTIVE INGREDIENT IN TONMYA (CYCLOBENZAPRINE HCL SUBLINGUAL TABLETS) Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-23T20:06:00.000+02:00",
    "crawled": "2018-01-24T15:14:59.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "tonix",
        "pharmaceutical",
        "holding",
        "corp",
        "tonix",
        "pharmaceutical",
        "receives",
        "notice",
        "allowance",
        "new",
        "patent",
        "active",
        "ingredient",
        "tonmya",
        "cyclobenzaprine",
        "hcl",
        "sublingual",
        "tablet",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}